See other companies on Welcome to the Jungle
Cardiosense
Digital biomarker platform
- 21-100 employees
- Healthcare
- B2B
- Artificial Intelligence
- SaaS
- West Loop, Chicago, IL
Jump to section
Company mission
To use physiological waveform data to predict cardiac illness and enable early interventions so people can enjoy healthier, longer lives.
Our take
Very often heart conditions and diseases can go undetected until substantial symptoms come to light. A recent study showed 50% to 80% of all heart attacks are silent. Cardiosense is developing AI powered technology to mine raw biosignals for unprecedented visibility into cardiac function.
In a very short space of time the company created its wearable CardioTag Sensor, developed its Wavesense Platform allowing the data to be seen in a clear dashboard and use Clinical AI to work to find digital biomarkers for early disease detection.
Cardiosense is hitting the ground running securing serious funding, which has allowed the company to grow its team, accelerate product development, and fund an expansive heart failure study. The impressive list of partners backing the company speaks to the excitement around this innovative product.
Freddie
Company Specialist at Welcome to the Jungle
Funding (1 round)
Dec 2022
$15.1m
SERIES A
Total funding: $15.1m
Leadership
Amit Gupta
(Co-founder)Worked as a Product and Strategy Advisor at Seastar Labs Inc. Moved through several roles at Ishi Systems Inc, most recently as Director of Product in Analytics.
Andrew Carek
(Co-founder)Doctor of Philosophy - PhD in Electrical and Electronics Engineering. Went onto become a Research Intern after studying and Postdoctoral Researcher at Northwestern University.